Tolerability of concurrent external beam radiotherapy and [ 177 Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial).

Esmée C A van der SarArthur J A T BraatJochem R N van der Voort-van ZypBetty S van der VeenPim J van LeeuwenDaphne M V de Vries-HuizingJeroen M A HendrikxMarnix G E H LamWouter V Vogel

Published in: BMC cancer (2023)

ClinicalTrials, NCT05162573 . Registered 7 October 2021.

Keyphrases

prostate cancer
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
locally advanced
early stage
clinical trial
peritoneal dialysis
radiation therapy
lymph node
pet ct
study protocol
radical prostatectomy
open label
randomized controlled trial
phase iii
pet imaging
combination therapy